Literature DB >> 2011051

Systemic absorption of L- and D-phenylalanine across the rat nasal mucosa.

P Tengamnuay1, Z Z Shao, A K Mitra.   

Abstract

Nasal absorption of L-phenylalanine (L-Phe) and D-phenylalanine (D-Phe) have been investigated in rats using an in vivo absorption technique. L-Phe was effectively absorbed into systemic circulation with peak plasma level at 45 min after nasal administration. The absolute nasal bioavailability was calculated to be 96.3% when 5 mg/kg dose was given to fasted rats. The absolute bioavailability declined to 66.8% when 12.5 mg/kg of L-Phe was given intranasally while the time to reach peak concentration remained at 45 min. The results substantiated previous in situ data that, despite its high polarity, L-Phe was transported across the rat nasal mucosa into blood stream by the large neutral amino acid (LNAA) carrier. The carrier showed partial saturation at higher doses. On the other hand, when 5 mg/kg of D-Phe was given intranasally, slow and incomplete absorption was observed resulting in a peak time of 60 min and an absolute bioavailability of only 35.2%, suggesting specificity of the carrier for natural L-amino acids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011051     DOI: 10.1016/0024-3205(91)90185-e

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol, and lucifer yellow.

Authors:  P M Reardon; C H Gochoco; K L Audus; G Wilson; P L Smith
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

2.  In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved.

Authors:  Remigius Agu; Hoang Vu Dang; Mark Jorissen; Tom Willems; Sandy Vandoninck; Johan Van Lint; Jackie V Vandenheede; Renaat Kinget; Norbert Verbeke
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.